Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report

Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent chronic liver disorders worldwide. It is closely associated with metabolic syndrome components, including type 2 diabetes, hyperlipidaemia and obesity. To date, no effective drug treatment is available for NAFLD but several clinic...

Descripción completa

Detalles Bibliográficos
Autor principal: Chantarojanasiri, Tanyaporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108664/
https://www.ncbi.nlm.nih.gov/pubmed/37077770
http://dx.doi.org/10.7573/dic.2023-1-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108664/
https://www.ncbi.nlm.nih.gov/pubmed/37077770
http://dx.doi.org/10.7573/dic.2023-1-4

Ejemplares similares